HHS/ASPE. U. S. Department of Health and Human Services.Background

Expanding the Use of Generic Drugs

Long Description for Figure 1

[ Issue Brief | Contents of Issue Brief | Figure 1 ]

Figure 1 Data:
Average Relative Price of Generic to Brand
by Number of Generic Competitors.
Number of Generic Manufacturers Average Relative Price per Dose
1 94%
2 52%
3 44%
4 39%
5 33%
6 26%
7 23%
8 21%
9 20%
10 26%
11 22%
12 20%
13 24%
14 15%
15 13%
16 11%
17 9%
18 8%
19 6%

Where to?

Top of Page

Home Pages:
Science and Data Policy (SDP)
Assistant Secretary for Planning and Evaluation (ASPE)
U.S. Department of Health and Human Services (HHS)